Brainstorm Health: MD Anderson Purge, Medicare Funds, Keytruda Approval

Sy Mukherjee
Updated
0

Happy Monday, readers! I hope you had a wonderful weekend.

On this Earth Day, it’s worth keeping a few facts in mind about the interplay between our personal health and our planet’s health.

Consider the words from the federal government’s own Office of Disease Prevention and Health Promotion: “Humans interact with the environment constantly. These interactions affect quality of life, years of healthy life lived, and health disparities. The World Health Organization (WHO) defines environment, as it relates to health, as ‘all the physical, chemical, and biological factors external to a person, and all the related behaviors.’ Environmental health consists of preventing or controlling disease, injury, and disability related to the interactions between people and their environment.”

That’s an excerpt from the Health People 2020 project (launched all the way back in 2010). The objectives of “promoting health for all through a healthy environment” are still in place, as the active Twitter account goes to show.

Just how strongly do these environmental issues affect our day-to-day lives and health? “Globally, 23% of all deaths and 26% of deaths among children under age 5 are due to preventable environmental factors,” according to the World Health Organization (WHO).

Air and water quality, the specter of toxic substances in the very places we live, and inequities in infrastructure can all mix up into a deadly cocktail. That’s a reality driving certain health care companies to put an increased focus on the “social determinants of health,” including these exact environmental factors.

That’s all well and good. But, if we’re to believe that the environment is this critical to health, it’s going to take more than the medical industry itself to address the problem.

Read on for the day’s news.

Sy Mukherjee @the_sy_guy sayak.mukherjee@fortune.com

  • DIGITAL HEALTH

    MD Anderson ousts three scientists over data theft concerns. One of the nation’s most prominent cancer centers, Texas’ MD Anderson, has booted three scientists over concerns they may have been involved in an alleged conspiracy to steal American research for China. The National Institutes of Health had reportedly informed the center of certain conflicts of interest and unreported foreign income. (NBC News)

  • INDICATIONS

    Merck snags another key approval for cancer drug Keytruda. Merck’s flagship cancer immunotherapy treatment Keytruda has snagged yet another pioneering Food and Drug Administration (FDA) indication—a first-line (a.k.a, it’s the first series of treatments that can be prescribed to patients in this particular condition) that combined Keytruda with a Pfizer cancer drug for kidney cancer. The approval ups the ante for rival Bristol-Myers Squibb and its own cancer immunotherapy treatment Opdivo in the kidney cancer space. (FiercePharma)

  • THE BIG PICTURE

    CMS chief uses latest Medicare report to slam universal health care. Centers for Medicare & Medicaid Services (CMS) chief Seema Verma pounced on the latest Medicare report finding that its funds will lapse by 2026. “At a time when some are calling for a complete government takeover of the American health-care system, the Medicare trustees have delivered a dose of reality,” Verma said in a statement. The administrator has been a harsh critic of universal health care proposals, including of many of the programs that she oversees. (Fortune)

  • REQUIRED READING

    Congress Weighs New Banking Laws That Could Light Up the Pot Business, by Rey Mashayekhi

    The World’s Best Recyclers Are Confounded by the Scourge of Plastic, by Katherine Dunn

    On Earth Day, a Call for Recycling Innovation, by Aaron Pressman

    PepsiCo Is Leaving Behind Bottles and Soda in Its Latest Product Launch, by Beth Kowitt

    Produced by Sy Mukherjee @the_sy_guy sayak.mukherjee@fortune.com Find past coverage. Sign up for other Fortune newsletters.

Advertisement

Recommended Stories

  • Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

    The popular growth investor added to these three existing positions on Tuesday.

  • Here's Exactly When Social Security Recipients Can Expect Benefit Cuts, According to the Latest Trustees Report

    Social Security payments may be subject to cuts. Here's what the timing looks like.

  • Morgan Stanley Predicts up to 110% Rally for These 2 ‘Strong Buy’ Stocks

    Uncertainty is the word of the day, in reference to the near-term economic future. Sentiment will hinge on the inflation numbers due out next week. March’s figure rose to 3.5%, and April’s job numbers showed a marked slowing in the labor market; that combination has stoked fears of stagflation. But – corporate earnings from Q1 are beating expectations, and the stock market has taken a turn for the better with the S&P 500 closing just below 5,200 yesterday. Economic strategists are still optimist

  • Can I Use My RMDs to Transfer Money Into My Roth IRA?

    If you're taking a required minimum distribution from an IRA, 401(k) or other tax-deferred account and don't need the money to cover living expenses, where should you stash that unneeded cash? Investors now need to start taking RMDs at age 73 or, if they were born after 1960, at age 75. Depending on the balances of […] The post Can I Use My RMDs to Transfer Money Into My Roth IRA? appeared first on SmartReads by SmartAsset.

  • How Much Cash Can A $300,000 Annuity Generate For Me Each Month?

    Imagine having a reliable source of income you can count on throughout your retirement. That’s the promise of an annuity. These insurance products have been designed to turn your savings into a steady stream of monthly payments. They guarantee peace of mind and financial security in your golden years. Don't Miss: Are you rich? Here’s what Americans think you need to be considered wealthy. Can you guess how many Americans successfully retire with $1,000,000 saved? The percentage may shock you. An

  • Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?

    Pfizer stock ran up to its 50-day line after the company reported better-than-expected sales and profit. Is PFE stock a buy?

  • 3 Ridiculously Undervalued Stocks to Buy Hand Over Fist Right Now in May

    Investing in cheap stocks brings unique risks because there is usually a reason the companies are undervalued.

  • Stocks could tank after an ill-advised 'melt-up' if the Fed cuts rates to avoid recession

    "Investors' expectation that the Fed would nip a recession in the bud by easing means that the Fed Put is back," Ed Yardeni said.

  • Real Estate Developer Soaked by Multimillion Dollar Loss on San Francisco Office Building

    Real estate developer Clarion Properties took a $60 million loss on a San Francisco office building it bought five years ago. The property at 410 Townsend Street is a four-story, 76,000-square-foot building. During the halcyon days of the tech industry, 410 Townsend was known as a startup village and was valued at $1,100 per square foot. That adds up to $86 million, which is what Clarion Partners bought the property for in 2019. That high price is emblematic of the high valuations of prime offic

  • IBM’s Red Hat Sued by Stephen Miller’s Legal Group for Anti-White Male Bias

    (Bloomberg Law) -- Ex-Trump adviser Stephen Miller’s legal group has sued IBM Corp. subsidiary Red Hat Inc. claiming the company’s diversity goals led to the discriminatory treatment and termination of a former White male employee. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t TrackStormy Daniels Will Return to Court in Test of Trump’s DemeanorTrump Judge Indefinitely Postpones Documents Case Tri